Cycurion (CYCU) Financials

Cycurion logo
$1.86 -0.17 (-8.37%)
Closing price 04:00 PM Eastern
Extended Trading
$1.86 0.00 (0.00%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Cycurion

Annual Income Statements for Cycurion

This table shows Cycurion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.70 -2.10 1.23 -24
Consolidated Net Income / (Loss)
-0.70 -2.10 1.23 -24
Net Income / (Loss) Continuing Operations
-0.70 -2.10 1.23 -24
Total Pre-Tax Income
-0.45 -2.09 1.23 -24
Total Operating Income
-2.02 0.33 2.42 -23
Total Gross Profit
0.00 2.64 3.63 1.61
Total Revenue
0.00 19 18 15
Operating Revenue
- 19 18 15
Total Cost of Revenue
0.00 17 14 14
Operating Cost of Revenue
- 17 14 14
Total Operating Expenses
2.02 2.32 1.22 25
Selling, General & Admin Expense
1.85 2.32 1.21 9.26
Other Operating Expenses / (Income)
0.16 - 0.01 3.90
Restructuring Charge
- - 0.00 12
Total Other Income / (Expense), net
1.57 -2.42 -1.19 -0.64
Interest Expense
- 2.07 1.21 0.54
Interest & Investment Income
1.57 0.00 0.02 0.03
Other Income / (Expense), net
0.00 -0.35 0.00 -0.13
Income Tax Expense
0.25 0.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - 0.00 -0.39
Basic Earnings per Share
($0.10) ($0.14) $4.35 ($13.44)
Weighted Average Basic Shares Outstanding
14.30M 14.78M 282.44K 1.76M
Diluted Earnings per Share
($0.10) ($0.14) $1.66 ($13.39)
Weighted Average Diluted Shares Outstanding
14.30M 14.78M 904.93K 1.76M
Weighted Average Basic & Diluted Shares Outstanding
4.02M - - 5.51M

Quarterly Income Statements for Cycurion

This table shows Cycurion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-1.34 -0.31 0.31 0.12 1.12 -10 -5.19 -3.12 -5.00 -2.13 -3.76
Consolidated Net Income / (Loss)
-1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56 -4.04
Net Income / (Loss) Continuing Operations
-1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56 -4.04
Total Pre-Tax Income
-1.40 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56 -4.04
Total Operating Income
1.14 -0.03 0.73 0.42 1.30 -10 -3.77 -4.53 -5.02 -2.37 -1.88
Total Gross Profit
2.64 0.35 1.02 0.72 1.55 0.68 0.24 0.27 0.43 0.69 1.09
Total Revenue
19 4.24 5.00 4.45 4.08 3.87 3.89 3.83 3.54 3.27 3.76
Operating Revenue
- 4.24 5.00 4.45 4.08 3.87 3.89 3.83 3.54 3.27 3.76
Total Cost of Revenue
17 3.90 3.98 3.73 2.53 3.19 3.65 3.56 3.11 2.58 2.66
Operating Cost of Revenue
- 3.90 3.98 3.73 2.53 3.19 3.65 3.56 3.11 2.58 2.66
Total Operating Expenses
1.50 0.38 0.29 0.30 0.25 11 4.00 4.80 5.45 3.06 2.98
Selling, General & Admin Expense
- 0.38 0.29 0.30 0.24 0.34 2.31 2.72 -8.24 2.74 2.64
Other Operating Expenses / (Income)
- - - 0.00 - 0.00 1.01 2.08 - 0.32 0.34
Restructuring Charge
- - - 0.00 - 10 0.68 0.00 - 0.00 0.00
Total Other Income / (Expense), net
-2.54 -0.28 -0.42 -0.30 -0.18 -0.15 -1.52 1.29 -0.26 -0.19 -2.15
Interest Expense
- 0.23 0.48 0.32 0.18 0.04 1.52 -1.30 0.29 0.20 2.16
Interest & Investment Income
-0.33 - 0.02 0.00 - 0.00 0.00 0.00 - 0.01 0.00
Other Income / (Expense), net
-0.13 -0.05 0.04 0.02 -0.00 -0.11 -0.00 -0.01 -0.00 0.00 0.00
Income Tax Expense
-0.06 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - 0.00 - 0.00 -0.10 -0.12 - -0.43 -0.28
Basic Earnings per Share
$0.22 ($0.02) $0.02 $0.23 $3.97 ($15.57) ($4.31) ($1.59) ($2.84) ($0.47) ($0.41)
Weighted Average Basic Shares Outstanding
14.78M 14.86M 14.97M 498.94K 282.44K 658.22K 1.20M 1.97M 1.76M 4.56M 9.07M
Diluted Earnings per Share
$0.22 ($0.02) $0.01 $0.11 $3.97 ($7.40) ($3.38) ($1.59) ($2.84) ($0.47) ($0.41)
Weighted Average Diluted Shares Outstanding
14.78M 14.86M 32.38M 1.12M 904.93K 1.38M 1.53M 1.97M 1.76M 4.56M 9.07M
Weighted Average Basic & Diluted Shares Outstanding
0.00 - - 3.42M 0.00 31.44M 51.43M 2.71M 5.51M 8.59M 25.84M

Annual Cash Flow Statements for Cycurion

This table details how cash moves in and out of Cycurion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.81 0.51 -0.57 5.21
Net Cash From Operating Activities
-1.32 -1.99 -1.37 -12
Net Cash From Continuing Operating Activities
-1.32 -1.99 -1.37 -12
Net Income / (Loss) Continuing Operations
-0.70 -2.10 1.23 -24
Consolidated Net Income / (Loss)
-0.70 -2.10 1.23 -24
Depreciation Expense
- 0.03 0.01 0.02
Amortization Expense
- 1.09 0.02 0.27
Non-Cash Adjustments To Reconcile Net Income
-1.57 0.32 0.01 12
Changes in Operating Assets and Liabilities, net
0.95 -1.33 -2.65 -0.61
Net Cash From Investing Activities
-116 -0.71 -0.89 1.41
Net Cash From Continuing Investing Activities
-116 -0.71 -0.89 1.41
Purchase of Property, Plant & Equipment
- -0.51 -0.45 -0.46
Divestitures
- 0.00 0.00 0.03
Other Investing Activities, net
-116 -0.20 -0.44 1.83
Net Cash From Financing Activities
118 3.21 1.69 16
Net Cash From Continuing Financing Activities
118 3.21 1.69 16
Repayment of Debt
-0.08 -0.22 0.00 -1.43
Repurchase of Common Equity
-0.43 - 0.00 -1.00
Issuance of Debt
0.00 1.43 0.69 2.89
Issuance of Common Equity
118 2.00 1.00 15

Quarterly Cash Flow Statements for Cycurion

This table details how cash moves in and out of Cycurion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
1.02 -0.40 -0.01 -0.12 -0.03 2.23 -1.26 2.64 1.60 -3.23 -0.16
Net Cash From Operating Activities
-1.34 -0.27 -0.58 -0.32 -0.21 -2.75 -3.56 -2.47 -3.31 -2.89 -3.28
Net Cash From Continuing Operating Activities
-1.34 -0.27 -0.58 -0.32 -0.21 -2.75 -3.56 -2.47 -3.31 -2.89 -3.28
Net Income / (Loss) Continuing Operations
-1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56 -4.04
Consolidated Net Income / (Loss)
-1.34 -0.31 0.31 0.12 1.12 -10 -5.29 -3.24 -5.28 -2.56 -4.04
Non-Cash Adjustments To Reconcile Net Income
0.44 0.01 - - - 9.21 2.19 0.06 0.83 0.32 2.27
Changes in Operating Assets and Liabilities, net
-1.56 0.03 -0.89 -0.43 -1.36 -1.78 -0.62 0.66 1.13 -0.65 -1.51
Net Cash From Investing Activities
-115 -0.11 -0.49 -0.11 -0.19 1.80 -0.10 -0.09 -0.19 -0.13 0.15
Net Cash From Continuing Investing Activities
-115 -0.11 -0.49 -0.11 -0.19 1.80 -0.10 -0.09 -0.19 -0.13 0.15
Purchase of Property, Plant & Equipment
- -0.11 -0.13 -0.11 -0.10 -0.07 -0.10 -0.09 -0.19 -0.13 -0.06
Acquisitions
- - - - - 0.03 - - - 0.00 0.21
Net Cash From Financing Activities
117 -0.02 1.06 0.30 0.36 3.17 2.41 5.20 5.10 -0.21 2.98
Net Cash From Continuing Financing Activities
117 -0.02 1.06 0.30 0.36 3.17 2.41 5.20 5.10 -0.21 2.98
Repayment of Debt
- -0.01 - - 0.01 -0.03 -0.21 -0.39 -0.80 -0.21 -0.30

Annual Balance Sheets for Cycurion

This table presents Cycurion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
0.33 118 21 26 33
Total Current Assets
0.00 1.08 8.41 11 8.00
Cash & Equivalents
0.00 0.81 0.61 0.04 5.26
Accounts Receivable
- 0.00 7.55 11 2.69
Prepaid Expenses
0.00 0.27 0.06 0.10 0.06
Plant, Property, & Equipment, net
0.00 0.00 0.03 0.02 0.00
Total Noncurrent Assets
0.32 117 12 15 25
Goodwill
- - 6.59 6.59 21
Other Noncurrent Operating Assets
0.32 117 5.71 3.84 4.61
Total Liabilities & Shareholders' Equity
0.33 118 21 26 33
Total Liabilities
0.31 1.24 16 20 17
Total Current Liabilities
0.31 1.24 14 19 17
Short-Term Debt
0.08 0.00 5.55 7.36 3.13
Accounts Payable
0.01 0.83 2.07 1.68 1.31
Accrued Expenses
0.23 - 2.16 2.93 4.23
Current Employee Benefit Liabilities
- - - 0.98 0.92
Other Taxes Payable
- 0.00 0.00 1.16 1.17
Other Current Liabilities
0.00 0.16 4.08 3.04 4.80
Other Current Nonoperating Liabilities
- - - 1.59 1.35
Total Noncurrent Liabilities
0.00 0.00 1.44 1.44 0.30
Long-Term Debt
- - 0.15 0.15 0.30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.01 -0.26 5.25 3.47 16
Total Preferred & Common Equity
0.01 -0.26 5.25 3.47 20
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
0.01 -0.26 5.25 3.47 20
Common Stock
0.03 1.61 9.68 6.67 47
Retained Earnings
-0.01 -1.86 -4.43 -3.20 -27
Noncontrolling Interest
- - - 0.00 -3.86

Quarterly Balance Sheets for Cycurion

This table presents Cycurion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
3.66 3.08 2.75 2.91 32 31 32 31 38
Total Current Assets
0.41 0.11 0.15 0.31 6.72 5.59 7.04 5.47 5.95
Cash & Equivalents
0.30 0.00 0.00 - 2.27 1.01 3.65 2.03 1.87
Accounts Receivable
- 0.11 0.09 0.06 4.34 4.52 3.33 3.34 3.85
Prepaid Expenses
0.10 0.00 0.04 0.02 0.11 0.05 0.06 0.11 0.22
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.00
Total Noncurrent Assets
3.25 2.97 2.60 2.60 25 25 25 26 32
Goodwill
- - - - 21 21 21 21 28
Other Noncurrent Operating Assets
3.25 2.97 2.60 2.60 4.23 4.34 4.43 - 4.80
Total Liabilities & Shareholders' Equity
3.66 3.08 2.75 2.91 32 31 32 31 38
Total Liabilities
3.28 2.89 3.44 3.98 22 20 17 18 20
Total Current Liabilities
2.61 2.76 3.33 3.90 22 20 17 17 20
Short-Term Debt
0.20 0.31 0.57 0.81 7.15 6.53 6.17 2.92 5.11
Accounts Payable
0.95 1.22 1.60 1.85 5.67 5.09 2.51 1.44 1.29
Accrued Expenses
- - - - 4.23 3.85 4.05 4.28 7.61
Current Employee Benefit Liabilities
- - - - - - - 1.31 1.06
Other Taxes Payable
1.14 1.15 1.15 1.15 1.17 1.17 1.17 1.17 1.17
Other Current Liabilities
- - - 0.08 3.62 3.36 2.71 4.86 2.86
Other Current Nonoperating Liabilities
- - - - - - - 1.49 0.43
Total Noncurrent Liabilities
0.66 0.13 0.11 0.08 0.30 0.30 0.30 0.30 0.63
Long-Term Debt
- - - - 0.30 0.30 0.30 0.30 0.63
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-2.89 -2.78 -3.37 -3.74 9.40 10 15 14 18
Total Preferred & Common Equity
-2.89 -2.78 -3.37 -3.74 13 14 19 18 23
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-2.89 -2.78 -3.37 -3.74 13 14 19 18 23
Common Stock
0.00 0.00 0.12 0.12 26 33 41 47 56
Retained Earnings
-2.89 -2.78 -3.49 -3.86 -13 -19 -22 -29 -33
Noncontrolling Interest
- - - - -3.46 -3.57 -3.68 -4.29 -4.57

Annual Metrics And Ratios for Cycurion

This table displays calculated financial ratios and metrics derived from Cycurion's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
14,751,000.00 3,556,410.00 3,424,879.00 2,712,489.00
DEI Adjusted Shares Outstanding
491,700.00 118,547.00 114,163.00 2,712,489.00
DEI Earnings Per Adjusted Shares Outstanding
-1.43 -17.69 10.77 -8.72
Growth Metrics
- - - -
Revenue Growth
0.00% 0.00% -8.16% -14.84%
EBITDA Growth
0.00% 154.59% 123.06% -1,047.15%
EBIT Growth
0.00% 99.05% 12,739.87% -1,073.36%
NOPAT Growth
0.00% 116.19% 957.44% -778.38%
Net Income Growth
0.00% -199.18% 158.64% -2,056.66%
EPS Growth
0.00% -40.00% 158.64% -906.63%
Operating Cash Flow Growth
0.00% -50.77% 31.01% -781.39%
Free Cash Flow Firm Growth
0.00% 0.00% -101.59% -952.12%
Invested Capital Growth
0.00% -91.11% 39.65% 9.17%
Revenue Q/Q Growth
0.00% 0.00% -46.22% -3.41%
EBITDA Q/Q Growth
0.00% 176.54% 15.36% -37.46%
EBIT Q/Q Growth
0.00% 98.67% 13.64% -36.66%
NOPAT Q/Q Growth
0.00% 126.63% 53.10% -36.97%
Net Income Q/Q Growth
0.00% -447.46% 200.01% -36.24%
EPS Q/Q Growth
0.00% 53.33% 200.01% -49.94%
Operating Cash Flow Q/Q Growth
0.00% -137.17% 45.29% -34.63%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -177.84% 41.90%
Invested Capital Q/Q Growth
0.00% 3,566.14% 4,867.79% -13.48%
Profitability Metrics
- - - -
Gross Margin
0.00% 13.66% 20.45% 10.65%
EBITDA Margin
0.00% 5.69% 13.82% -153.68%
Operating Margin
0.00% 1.69% 13.60% -154.72%
EBIT Margin
0.00% -0.10% 13.61% -155.58%
Profit (Net Income) Margin
0.00% -10.84% 6.92% -158.98%
Tax Burden Percent
155.70% 100.18% 100.00% 100.00%
Interest Burden Percent
22.32% 10,938.11% 50.83% 102.19%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.36% 19.50% -108.54%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -108.23% 2.73% -287.46%
Return on Net Nonoperating Assets (RNNOA)
0.00% -3.79% 3.63% -113.93%
Return on Equity (ROE)
-1.20% -3.43% 23.13% -222.48%
Cash Return on Invested Capital (CROIC)
0.00% 167.69% -13.59% -117.31%
Operating Return on Assets (OROA)
0.00% -0.03% 10.44% -79.79%
Return on Assets (ROA)
0.00% -3.02% 5.30% -81.54%
Return on Common Equity (ROCE)
0.00% -0.14% 18.96% -242.43%
Return on Equity Simple (ROE_SIMPLE)
273.39% -39.97% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-1.41 0.23 2.42 -16
NOPAT Margin
0.00% 1.18% 13.60% -108.30%
Net Nonoperating Expense Percent (NNEP)
87.80% 108.59% 16.77% 178.92%
Return On Investment Capital (ROIC_SIMPLE)
- 2.09% 22.02% -83.33%
Cost of Revenue to Revenue
0.00% 86.34% 79.55% 89.35%
SG&A Expenses to Revenue
0.00% 11.97% 6.80% 61.18%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 11.97% 6.86% 165.37%
Earnings before Interest and Taxes (EBIT)
-2.02 -0.02 2.42 -24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-2.02 1.10 2.46 -23
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 7.36 10.35 0.37
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 2.00 2.02 0.49
Price to Earnings (P/E)
0.00 0.00 29.19 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 3.43% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.47 4.23 3.14 0.11
Enterprise Value to Revenue (EV/Rev)
0.00 2.26 2.55 0.12
Enterprise Value to EBITDA (EV/EBITDA)
0.00 39.71 18.44 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 18.72 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 191.32 18.74 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.41 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 1.09 1.39 0.21
Long-Term Debt to Equity
0.00 0.03 0.03 0.02
Financial Leverage
-0.01 0.04 1.33 0.40
Leverage Ratio
1.01 1.14 4.36 2.73
Compound Leverage Factor
0.23 124.40 2.22 2.79
Debt to Total Capital
0.00% 52.08% 58.22% 17.42%
Short-Term Debt to Total Capital
0.00% 50.73% 57.08% 15.89%
Long-Term Debt to Total Capital
0.00% 1.34% 1.14% 1.53%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
100.22% 0.00% 14.88% -19.61%
Common Equity to Total Capital
-0.22% 47.92% 26.91% 102.19%
Debt to EBITDA
0.00 5.18 3.06 -0.15
Net Debt to EBITDA
0.00 4.63 3.04 0.08
Long-Term Debt to EBITDA
0.00 0.13 0.06 -0.01
Debt to NOPAT
0.00 24.95 3.11 -0.21
Net Debt to NOPAT
0.00 22.29 3.09 0.11
Long-Term Debt to NOPAT
0.00 0.64 0.06 -0.02
Altman Z-Score
82.14 1.79 1.53 -3.05
Noncontrolling Interest Sharing Ratio
100.21% 95.92% 18.03% -8.97%
Liquidity Ratios
- - - -
Current Ratio
0.87 0.60 0.58 0.47
Quick Ratio
0.65 0.59 0.58 0.47
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 106 -1.68 -18
Operating Cash Flow to CapEx
0.00% -392.29% -306.09% -2,656.34%
Free Cash Flow to Firm to Interest Expense
0.00 51.17 -1.39 -32.67
Operating Cash Flow to Interest Expense
0.00 -0.96 -1.13 -22.29
Operating Cash Flow Less CapEx to Interest Expense
0.00 -1.20 -1.50 -23.13
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.28 0.77 0.51
Accounts Receivable Turnover
0.00 0.00 1.94 2.25
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 658.41 0.00
Accounts Payable Turnover
0.00 11.54 7.54 9.02
Days Sales Outstanding (DSO)
0.00 0.00 188.31 162.51
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 31.64 48.39 40.45
Cash Conversion Cycle (CCC)
0.00 -31.64 139.92 122.06
Capital & Investment Metrics
- - - -
Invested Capital
116 10 14 16
Invested Capital Turnover
0.00 0.31 1.43 1.00
Increase / (Decrease) in Invested Capital
0.00 -106 4.10 1.32
Enterprise Value (EV)
287 44 45 1.80
Market Capitalization
170 39 36 7.49
Book Value per Share
($0.02) $1.48 $1.01 $7.41
Tangible Book Value per Share
($0.02) ($0.39) ($2.13) ($1.97)
Total Capital
117 11 13 20
Total Debt
0.00 5.70 7.50 3.43
Total Long-Term Debt
0.00 0.15 0.15 0.30
Net Debt
-0.81 5.09 7.46 -1.83
Capital Expenditures (CapEx)
0.00 0.51 0.45 0.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.98 -0.75 -0.49 -11
Debt-free Net Working Capital (DFNWC)
-0.17 -0.14 -0.45 -5.78
Net Working Capital (NWC)
-0.17 -5.69 -7.81 -8.91
Net Nonoperating Expense (NNE)
-0.71 2.33 1.19 7.67
Net Nonoperating Obligations (NNO)
-0.81 5.09 9.05 -0.48
Total Depreciation and Amortization (D&A)
0.00 1.12 0.04 0.29
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -3.87% -2.77% -72.92%
Debt-free Net Working Capital to Revenue
0.00% -0.73% -2.54% -38.19%
Net Working Capital to Revenue
0.00% -29.43% -43.94% -58.85%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
($0.10) ($0.50) $2.40 ($13.44)
Adjusted Weighted Average Basic Shares Outstanding
14.30M 4.09M 498.94K 1.76M
Adjusted Diluted Earnings per Share
($0.10) ($0.50) $0.60 ($13.39)
Adjusted Weighted Average Diluted Shares Outstanding
14.30M 4.09M 2.98M 1.76M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
4.02M 0.00 0.00 5.51M
Normalized Net Operating Profit after Tax (NOPAT)
-1.41 0.23 1.69 -8.08
Normalized NOPAT Margin
0.00% 1.18% 9.52% -53.40%
Pre Tax Income Margin
0.00% -10.82% 6.92% -158.98%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 -0.01 2.00 -43.42
NOPAT to Interest Expense
0.00 0.11 2.00 -30.23
EBIT Less CapEx to Interest Expense
0.00 -0.25 1.63 -44.26
NOPAT Less CapEx to Interest Expense
0.00 -0.13 1.63 -31.07
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-61.49% 0.00% 0.00% -4.16%

Quarterly Metrics And Ratios for Cycurion

This table displays calculated financial ratios and metrics derived from Cycurion's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
3,556,410.00 3,556,410.00 3,525,267.00 3,497,472.00 3,424,879.00 3,424,879.00 31,443,906.00 51,426,037.00 2,712,489.00 5,509,988.00 8,590,021.00
DEI Adjusted Shares Outstanding
118,547.00 118,547.00 117,509.00 116,582.00 114,163.00 114,163.00 1,048,130.00 1,714,201.00 2,712,489.00 5,509,988.00 8,590,021.00
DEI Earnings Per Adjusted Shares Outstanding
-11.30 -2.64 2.60 1.00 9.81 -89.77 -5.05 -1.82 -1.84 -0.39 -0.44
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% -78.93% -8.79% -22.26% -13.87% -13.10% -15.54% -3.37%
EBITDA Growth
343.13% 75.63% 288.34% 249.88% 31.86% -12,762.91% -568.35% -1,127.44% -478.06% 76.62% 47.77%
EBIT Growth
343.13% 74.95% 287.80% 249.13% 28.88% -12,506.48% -590.35% -1,143.21% -487.40% 76.78% 49.97%
NOPAT Growth
376.11% 91.20% 624.37% 342.25% 63.14% -31,197.48% -461.44% -857.38% -370.27% 76.52% 49.96%
Net Income Growth
-457.38% -82.08% 192.05% 145.77% 183.62% -3,179.78% -1,828.36% -2,890.88% -571.49% 75.00% 23.64%
EPS Growth
266.67% 66.67% 106.25% 145.77% 183.62% -3,179.78% -1,600.00% -2,890.88% -171.54% 93.65% 87.87%
Operating Cash Flow Growth
-600.88% 30.71% -491.24% -102.20% 84.66% -907.58% -515.61% -683.32% -1,511.33% -5.27% 7.69%
Free Cash Flow Firm Growth
0.00% -95.47% -94.40% -99.13% -102.62% -522.08% -407.69% -2,261.53% -72.81% 83.72% 60.24%
Invested Capital Growth
-91.11% -91.12% -102.53% -207.39% 39.65% 2,869.64% 12,180.63% 6,116.15% 9.17% 12.24% 38.43%
Revenue Q/Q Growth
0.00% -78.07% 17.88% -11.01% -8.39% -5.07% 0.46% -1.41% -7.58% -7.74% 14.94%
EBITDA Q/Q Growth
444.12% -107.84% 1,077.67% -43.15% 202.74% -864.50% 64.40% -24.70% -11.40% 52.72% 20.48%
EBIT Q/Q Growth
444.12% -108.06% 1,048.44% -43.28% 197.39% -887.97% 63.11% -20.68% -10.44% 52.77% 20.52%
NOPAT Q/Q Growth
561.03% -102.83% 3,329.58% -42.58% 210.48% -643.62% 62.70% -20.31% -10.79% 52.77% 20.52%
Net Income Q/Q Growth
-428.02% 76.67% 197.96% -62.07% 864.65% -1,015.13% 48.38% 38.76% -62.97% 51.48% -57.69%
EPS Q/Q Growth
257.14% -109.09% 150.00% -62.07% 864.65% -1,015.13% 73.21% 38.76% -78.62% 83.45% 12.77%
Operating Cash Flow Q/Q Growth
-760.32% 79.68% -112.14% 45.47% 34.74% -1,234.55% -29.61% 30.61% -34.25% 12.81% -13.65%
Free Cash Flow Firm Q/Q Growth
-7.82% -95.30% 23.40% -83.77% -378.94% -655.54% 10.05% -14.02% 77.70% 28.83% -119.75%
Invested Capital Q/Q Growth
3,566.14% -95.25% -127.42% -125.05% 4,867.79% 0.94% 11.54% 12.07% -13.48% 3.78% 37.57%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
13.66% 8.17% 20.48% 16.13% 37.92% 17.51% 6.07% 7.06% 12.09% 21.06% 29.10%
EBITDA Margin
5.20% -1.86% 15.40% 9.84% 32.52% -261.92% -92.81% -117.39% -141.49% -72.51% -50.16%
Operating Margin
5.88% -0.76% 14.58% 9.41% 31.89% -260.91% -96.87% -118.21% -141.71% -72.54% -50.16%
EBIT Margin
5.20% -1.91% 15.36% 9.79% 31.79% -263.85% -96.89% -118.60% -141.71% -72.54% -50.16%
Profit (Net Income) Margin
-6.92% -7.36% 6.12% 2.61% 27.47% -264.82% -136.07% -84.53% -149.05% -78.38% -107.52%
Tax Burden Percent
95.64% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
-139.26% 385.77% 39.84% 26.64% 86.42% 100.36% 140.44% 71.27% 105.18% 108.04% 214.33%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
1.26% -4.18% 160.84% 0.00% 45.75% -421.86% -136.99% -144.73% -99.41% -47.71% -26.09%
ROIC Less NNEP Spread (ROIC-NNEP)
-98.49% 726.56% -125.41% 0.00% 43.20% -537.90% -220.43% -148.55% -140.62% -70.69% -79.95%
Return on Net Nonoperating Assets (RNNOA)
-3.45% -9.46% -7.59% 0.00% 57.48% -307.62% -143.68% -36.97% -55.73% -24.04% -28.18%
Return on Equity (ROE)
-2.19% -13.63% 153.26% 361.11% 103.23% -729.48% -280.67% -181.69% -155.15% -71.76% -54.28%
Cash Return on Invested Capital (CROIC)
167.69% 182.74% 0.00% 0.00% -13.59% -258.05% -153.12% -167.34% -117.31% -82.54% -82.11%
Operating Return on Assets (OROA)
1.45% -7.69% 77.78% 98.43% 24.37% -265.34% -94.24% -105.51% -72.68% -33.48% -20.91%
Return on Assets (ROA)
-1.93% -29.68% 30.99% 26.22% 21.06% -266.31% -132.35% -75.20% -76.44% -36.17% -44.81%
Return on Common Equity (ROCE)
-0.09% 10.97% -185.50% 3,518.73% 84.62% -767.56% -306.19% -194.41% -169.06% -95.87% -69.70%
Return on Equity Simple (ROE_SIMPLE)
0.00% 80.49% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
0.80 -0.02 0.73 0.42 1.30 -7.07 -2.64 -3.17 -3.51 -1.66 -1.32
NOPAT Margin
4.12% -0.53% 14.58% 9.41% 31.89% -182.64% -67.81% -82.75% -99.19% -50.78% -35.11%
Net Nonoperating Expense Percent (NNEP)
99.75% -730.74% 286.25% 91.71% 2.55% 116.04% 83.44% 3.82% 41.20% 22.98% 53.86%
Return On Investment Capital (ROIC_SIMPLE)
7.28% 0.91% -26.07% -14.26% 11.85% -41.96% -15.26% -14.50% -17.87% -9.82% -5.51%
Cost of Revenue to Revenue
86.34% 91.83% 79.52% 83.87% 62.08% 82.49% 93.93% 92.94% 87.91% 78.94% 70.90%
SG&A Expenses to Revenue
0.00% 8.93% 5.89% 6.72% 5.78% 8.72% 102.93% 70.95% -232.56% 83.94% 70.30%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
7.78% 8.93% 5.89% 6.72% 6.03% 278.43% 102.93% 125.27% 153.79% 93.60% 79.26%
Earnings before Interest and Taxes (EBIT)
1.01 -0.08 0.77 0.44 1.30 -10 -3.77 -4.55 -5.02 -2.37 -1.88
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1.01 -0.08 0.77 0.44 1.33 -10 -3.61 -4.50 -5.01 -2.37 -1.88
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.36 0.00 0.00 0.00 10.35 0.13 0.78 1.06 0.37 0.31 0.22
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.00 1.60 1.37 1.12 2.02 0.10 0.67 1.29 0.49 0.38 0.35
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 29.19 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 3.43% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
4.23 83.77 0.00 0.00 3.14 0.23 0.81 1.06 0.11 0.15 0.19
Enterprise Value to Revenue (EV/Rev)
2.26 1.74 1.48 1.23 2.55 0.20 0.81 1.24 0.12 0.17 0.30
Enterprise Value to EBITDA (EV/EBITDA)
39.71 184.16 30.25 19.03 18.44 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 184.16 30.25 19.03 18.72 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
191.32 88.90 38.09 25.67 18.74 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.41 7.48 6.45 18.73 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.09 1.68 -0.83 -0.76 1.39 0.79 0.65 0.42 0.21 0.24 0.32
Long-Term Debt to Equity
0.03 0.00 0.00 0.00 0.03 0.03 0.03 0.02 0.02 0.02 0.03
Financial Leverage
0.04 -0.01 0.06 -0.97 1.33 0.57 0.65 0.25 0.40 0.34 0.35
Leverage Ratio
1.14 1.92 2.31 -9.65 4.36 3.61 3.43 2.46 2.73 2.73 2.41
Compound Leverage Factor
-1.58 7.41 0.92 -2.57 3.77 3.62 4.82 1.75 2.87 2.95 5.17
Debt to Total Capital
52.08% 62.62% -475.54% -312.85% 58.22% 44.19% 39.50% 29.54% 17.42% 19.04% 23.95%
Short-Term Debt to Total Capital
50.73% 62.62% -475.54% -312.85% 57.08% 42.44% 37.79% 28.19% 15.89% 17.27% 21.33%
Long-Term Debt to Total Capital
1.34% 0.00% 0.00% 0.00% 1.14% 1.75% 1.71% 1.35% 1.53% 1.78% 2.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 602.70% -2,237.88% -1,039.42% 14.88% -20.57% -20.65% -16.84% -19.61% -25.39% -19.11%
Common Equity to Total Capital
47.92% -565.32% 2,813.42% 1,452.27% 26.91% 76.38% 81.15% 87.30% 102.19% 106.35% 95.15%
Debt to EBITDA
5.18 1.38 0.41 0.38 3.06 -0.98 -0.57 -0.38 -0.15 -0.21 -0.42
Net Debt to EBITDA
4.63 1.38 0.40 0.36 3.04 -0.68 -0.48 -0.17 0.08 -0.08 -0.28
Long-Term Debt to EBITDA
0.13 0.00 0.00 0.00 0.06 -0.04 -0.02 -0.02 -0.01 -0.02 -0.05
Debt to NOPAT
24.95 0.67 0.51 0.51 3.11 -1.39 -0.80 -0.54 -0.21 -0.29 -0.59
Net Debt to NOPAT
22.29 0.66 0.50 0.48 3.09 -0.97 -0.68 -0.23 0.11 -0.11 -0.40
Long-Term Debt to NOPAT
0.64 0.00 0.00 0.00 0.06 -0.06 -0.03 -0.02 -0.02 -0.03 -0.06
Altman Z-Score
1.95 13.14 14.99 14.09 1.39 -1.64 -0.96 -0.56 -1.23 -1.35 -1.26
Noncontrolling Interest Sharing Ratio
95.92% 180.45% 221.04% -874.42% 18.03% -5.22% -9.09% -7.00% -8.97% -33.60% -28.41%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.60 0.04 0.04 0.08 0.58 0.31 0.28 0.42 0.47 0.31 0.30
Quick Ratio
0.59 0.04 0.03 0.06 0.58 0.30 0.28 0.42 0.47 0.31 0.29
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
107 5.01 6.18 1.00 -2.80 -21 -19 -22 -4.84 -3.44 -7.57
Operating Cash Flow to CapEx
0.00% -259.47% -434.56% -300.16% -195.90% -3,921.58% -3,421.17% -2,626.38% -1,772.43% -2,240.18% -5,213.24%
Free Cash Flow to Firm to Interest Expense
0.00 21.65 12.82 3.14 -15.91 -568.03 -12.49 0.00 -16.93 -16.81 -3.51
Operating Cash Flow to Interest Expense
0.00 -1.18 -1.20 -0.99 -1.17 -73.72 -2.34 0.00 -11.60 -14.11 -1.52
Operating Cash Flow Less CapEx to Interest Expense
0.00 -1.63 -1.47 -1.31 -1.77 -75.60 -2.40 0.00 -12.26 -14.74 -1.55
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.28 4.03 5.06 10.05 0.77 1.01 0.97 0.89 0.51 0.46 0.42
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 1.94 7.82 7.06 9.24 2.25 3.79 3.44
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 658.41 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
11.54 19.08 19.34 20.19 7.54 3.90 3.92 5.93 9.02 3.63 3.74
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 188.31 46.66 51.69 39.49 162.51 96.41 106.11
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
31.64 19.13 18.88 18.08 48.39 93.54 93.06 61.52 40.45 100.49 97.66
Cash Conversion Cycle (CCC)
-31.64 -19.13 -18.88 -18.08 139.92 -46.88 -41.37 -22.03 122.06 -4.08 8.46
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10 0.49 -0.13 -0.30 14 15 16 18 16 16 23
Invested Capital Turnover
0.31 7.84 11.03 -3,173.12 1.43 2.31 2.02 1.75 1.00 0.94 0.74
Increase / (Decrease) in Invested Capital
-106 -5.03 -5.45 -0.58 4.10 14 16 19 1.32 1.78 6.25
Enterprise Value (EV)
44 41 42 41 45 3.39 13 19 1.80 2.46 4.26
Market Capitalization
39 38 39 37 36 1.68 11 20 7.49 5.57 4.97
Book Value per Share
$1.48 ($0.78) ($0.96) ($1.06) $1.01 $3.76 $0.45 $0.37 $7.41 $6.63 $2.51
Tangible Book Value per Share
($0.39) ($0.78) ($0.96) ($1.06) ($2.13) ($2.25) ($0.22) ($0.03) ($1.97) ($2.95) ($0.53)
Total Capital
11 0.49 -0.12 -0.26 13 17 17 22 20 17 24
Total Debt
5.70 0.31 0.57 0.81 7.50 7.44 6.82 6.46 3.43 3.22 5.74
Total Long-Term Debt
0.15 0.00 0.00 0.00 0.15 0.30 0.30 0.30 0.30 0.30 0.63
Net Debt
5.09 0.31 0.55 0.76 7.46 5.17 5.81 2.81 -1.83 1.19 3.86
Capital Expenditures (CapEx)
0.00 0.11 0.13 0.11 0.10 0.07 0.10 0.09 0.19 0.13 0.06
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.75 -2.34 -2.62 -2.82 -0.49 -10 -8.89 -7.05 -11 -11 -10
Debt-free Net Working Capital (DFNWC)
-0.14 -2.34 -2.61 -2.78 -0.45 -7.96 -7.88 -3.40 -5.78 -9.07 -8.47
Net Working Capital (NWC)
-5.69 -2.65 -3.18 -3.58 -7.81 -15 -14 -9.57 -8.91 -12 -14
Net Nonoperating Expense (NNE)
2.14 0.29 0.42 0.30 0.18 3.18 2.65 0.07 1.77 0.90 2.72
Net Nonoperating Obligations (NNO)
5.09 0.31 0.55 0.76 9.05 5.17 5.81 2.81 -0.48 2.68 4.29
Total Depreciation and Amortization (D&A)
0.00 0.00 0.00 0.00 0.03 0.07 0.16 0.05 0.01 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
-3.87% -9.93% -9.17% -8.54% -2.77% -58.81% -54.61% -45.02% -72.92% -76.40% -71.84%
Debt-free Net Working Capital to Revenue
-0.73% -9.92% -9.12% -8.40% -2.54% -45.76% -48.38% -21.71% -38.19% -62.44% -58.83%
Net Working Capital to Revenue
-29.43% -11.23% -11.11% -10.84% -43.94% -86.85% -88.46% -61.06% -58.85% -82.52% -94.30%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.22 $0.12 ($0.20) ($3.30) $119.10 ($16.80) ($0.15) ($1.59) ($2.84) ($0.47) ($0.41)
Adjusted Weighted Average Basic Shares Outstanding
14.78M 282.82K 260.52K 8.22K 9.42K 609.05K 34.79M 1.97M 1.76M 4.56M 9.07M
Adjusted Diluted Earnings per Share
$0.22 $0.12 ($0.20) ($3.30) $119.10 ($16.80) ($0.15) ($1.59) ($2.84) ($0.47) ($0.41)
Adjusted Weighted Average Diluted Shares Outstanding
14.78M 282.82K 260.52K 8.22K 30.16K 609.05K 34.89M 1.97M 1.76M 4.56M 9.07M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $119.10 $0.00 $0.00 $0.00 ($2.84) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 0.00 114.16K 0.00 1.05M 51.43M 2.71M 5.51M 8.59M 25.84M
Normalized Net Operating Profit after Tax (NOPAT)
0.80 -0.02 0.51 0.29 0.91 0.24 -2.64 -3.17 -3.51 -1.66 -1.32
Normalized NOPAT Margin
4.12% -0.53% 10.21% 6.59% 22.32% 6.16% -67.81% -82.75% -99.19% -50.78% -35.11%
Pre Tax Income Margin
-7.24% -7.36% 6.12% 2.61% 27.47% -264.82% -136.07% -84.53% -149.05% -78.38% -107.52%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 -0.35 1.59 1.36 7.36 -274.22 -2.47 0.00 -17.57 -11.58 -0.87
NOPAT to Interest Expense
0.00 -0.10 1.51 1.31 7.39 -189.82 -1.73 0.00 -12.30 -8.10 -0.61
EBIT Less CapEx to Interest Expense
0.00 -0.80 1.32 1.03 6.77 -276.10 -2.54 0.00 -18.23 -12.20 -0.90
NOPAT Less CapEx to Interest Expense
0.00 -0.55 1.24 0.98 6.79 -191.70 -1.80 0.00 -12.96 -8.73 -0.64
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -4.16% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Cycurion’s second-quarter 2026 results show improved operating performance, but the company remains dependent on external financing and continues to report substantial losses. Revenue increased to $3.8 million from $3.3 million in the first quarter, while gross profit rose to $1.1 million from $688,000. Gross margin improved to approximately 29% from 21% in Q1 2026 and 6% in Q2 2025. However, revenue was still below the $3.9 million reported in Q2 2025 and well below the $5.0 million recorded in Q2 2024.

Operating expenses declined modestly to $3.0 million from $3.1 million in Q1, helping reduce the operating loss to $1.9 million from $2.4 million. Nevertheless, a sharp increase in interest expense to $2.2 million caused the pretax loss to widen to $4.0 million. The company reported a net loss attributable to common shareholders of $3.8 million, or $0.41 per share, compared with a $2.1 million loss, or $0.47 per share, in Q1 2026. The improvement in per-share losses should be viewed cautiously because weighted-average basic shares nearly doubled sequentially to 9.1 million.

Liquidity remains the most significant financial concern. Cycurion ended Q2 with $1.9 million of cash, down from $2.0 million in Q1, after generating negative operating cash flow of $3.3 million. Financing activities provided nearly $3.0 million, largely offsetting the operating cash burn. Current liabilities of $19.5 million were more than three times current assets of $6.0 million, producing a current ratio of approximately 0.30. Goodwill and other noncurrent operating assets also represented most of the company’s $38.4 million asset base, limiting the balance sheet’s tangible cushion.

  • Gross margin improved materially: Q2 2026 gross margin reached approximately 29%, up from about 21% in Q1 2026 and 6% in Q2 2025.
  • Operating loss narrowed sequentially: The operating loss improved to $1.9 million from $2.4 million in Q1 2026 and $3.8 million in Q2 2025.
  • Revenue recovered from the first quarter: Quarterly revenue rose approximately 15% sequentially to $3.8 million.
  • Debt repayment continued: Cycurion repaid approximately $304,000 of debt during Q2, although new financing more than offset the repayment.
  • Accounts receivable increased: Receivables rose to $3.9 million from $3.3 million in Q1, which could support future cash collections but also places greater importance on collection timing.
  • Asset growth was concentrated in noncurrent assets: Total assets increased to $38.4 million from $31.4 million in Q1, primarily because of higher goodwill and other noncurrent operating assets rather than cash or property.
  • Operating cash flow remained deeply negative: Cycurion used $3.3 million of cash in operations in Q2 2026, following operating cash outflows of $2.9 million in Q1 and $3.3 million in Q4 2025.
  • Interest expense surged: Quarterly interest expense increased to $2.2 million from $205,000 in Q1 2026, substantially worsening the pretax loss despite better operating results.
  • Short-term liquidity is weak: Current liabilities of $19.5 million substantially exceeded current assets of $6.0 million, while cash covered less than 10% of current liabilities.
  • Shareholder dilution is a major risk: Weighted-average basic shares rose to 9.1 million in Q2 from 4.6 million in Q1 2026 and 1.2 million in Q2 2025, while common stock on the balance sheet increased to $55.5 million.
11/18/26 11:16 PM ETAI Generated. May Contain Errors.

Cycurion Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cycurion's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Cycurion's net income appears to be on a downward trend, with a most recent value of -$24.06 million in 2025, falling from -$700.93 thousand in 2022. The previous period was $1.23 million in 2024. See where experts think Cycurion is headed by visiting Cycurion's forecast page.

Cycurion's total operating income in 2025 was -$23.41 million, based on the following breakdown:
  • Total Gross Profit: $1.61 million
  • Total Operating Expenses: $25.03 million

Over the last 3 years, Cycurion's total revenue changed from $0.00 in 2022 to $15.13 million in 2025, a change of 1,513,364,700.0%.

In the past 11 quarters, Cycurion's cash and equivalents has ranged from $0.00 in Q1 2024 to $3.65 million in Q3 2025, and is currently $1.87 million as of their latest financial filing in Q2 2026.

Cycurion had total debt of $3.43 million at the end of 2025, a 54.3% decrease from 2024, and none in 2022.

Over the last 3 years, Cycurion's book value per share changed from -0.02 in 2022 to 7.41 in 2025.



Financial statements for NASDAQ:CYCU last updated on 8/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners